# New York Presbyterian Ventures

> New York Presbyterian Ventures is a VC fund backing Health Care. See 10 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 10
- Last investment: Jul 2020
- Lead investor: 10%
- Last updated: Sep 2026
- LinkedIn: https://www.linkedin.com/company/new-york-presbyterian-hospital/
- X (Twitter): https://twitter.com/nyphospital
- Website: http://www.nypventures.org/
- Facebook: https://www.facebook.com/newyorkpresbyterian

New York Presbyterian Ventures is a VC fund in New York focused on Health Care and Machine Learning. NYP Ventures identifies and supports digital health innovations that have the potential to improve the quality and experience of care for the populations we serve. Our fund seeks to both invest in and build collaborative relationships with emerging businesses, leveraging internal expertise to support the development and growth of portfoliocompanies.

## Contacts

5 contacts available for New York Presbyterian Ventures. Shizune tracks 3 team members at New York Presbyterian Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/new-york-presbyterian-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 6 | 60% |
| Machine Learning | 6 | 60% |
| Artificial Intelligence | 5 | 50% |
| Software | 3 | 30% |
| Health Diagnostics | 3 | 30% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 4 | 40% |
| Series A | 2 | 20% |
| Seed | 1 | 10% |
| Series E | 1 | 10% |
| Convertible Note | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Todd Cohen | Investments | 0 | — |
| Daniel Barchi | Chief Information Officer | 0 | — |
| Jonathan Gordon | Director | 8 | https://shizune.co/investors/profile/jonathan-gordon-3 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Caption Health | Caption Health will use this funding to scale up its commercial operations, continue to develop its AI technology platform and form new partnerships. As more providers adopt the Caption AI platform, the company plans to add new clinical capabilities to expand the use of Caption AI in additional care settings. | $53M | Series B | Jul 15, 2020 |  |
| Saykara | Saykara is combatting physician burnout and elevating productivity through its ambient and autonomous AI assistant. Use of the company’s voice-enabled mobile app, Kara, is proven to reduce time spent charting by 70%, eliminate after-hours charting by 100%, and enhance note quality and completeness by 25%. Additionally, by freeing physicians fromkeyboards, computer screens and burdensome data entry, patients enjoy more personalized, less hurried visits. Kara is specialty agnostic, scalable at the enterprise level and available through a software-as-a-service (SaaS) subscription.Saykara was founded in 2015 by Harjinder Sandhu, a serial healthcare technology entrepreneur and former Nuance executive who has stood at the forefront of innovations in speech recognition and machine learning for more than 20 years.For additional information and to schedule a live demo, visit www.saykara.com or email info@saykara.com. | $5M | Seed | Sep 13, 2018 |  |
| Qventus | Qventus optimizes operational decisions in hospitals in real time. They use machine learning and optimization algorithms to help hospitals reduce costs, improve quality and experience of the healthcare they deliver.Qventus is a YCombinator and StartX company working with some of the top health institutions in the country to change how healthcareis run. | $30M | Series B | May 14, 2018 |  |
| WorkFusion | WorkFusion provides a platform of AI agents for automating business processes. The agents perform financial crime compliance functions, including sanctions screening and adverse media monitoring. The software is designed to improve operational efficiency for financial institutions. | $50M | Series E | Apr 05, 2018 |  |
| Caption Health | Caption Health will use this funding to scale up its commercial operations, continue to develop its AI technology platform and form new partnerships. As more providers adopt the Caption AI platform, the company plans to add new clinical capabilities to expand the use of Caption AI in additional care settings. |  | Convertible Note | Mar 01, 2018 |  |
| Arterys | Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions. | $30M | Series B | Nov 15, 2017 |  |
| CLARA Analytics | CLARA Analytics improves claims outcomes in commercial insurance with easy-to-use AI-based products. The company’s product suite applies image recognition, natural language processing, and other AI-based techniques to unlock insights from medical notes, bills and other documents surrounding a claim. CLARA’s predictive insight gives adjusters “AIsuperpowers” that help them reduce claim costs and optimize outcomes for the carrier, customer and claimant. CLARA’s customers include companies from the top 25 global insurance carriers to large third-party administrators and self-insured organizations. |  | Series A | Oct 01, 2017 |  |
| LeanTaaS | LeanTaaS is a software company whose offerings rely on advanced data science to significantly improve the operational performance of hospitals and clinics. Using the LeanTaaS iQueue platform, which is grounded in lean principles and predictive analytics, and in conjunction with existing EHRs, healthcare institutions are developing optimizedschedules that are tailored to each clinical site. This transformation helps healthcare providers increase patient access and satisfaction, decrease wait times, improve care provider satisfaction, and reduce healthcare delivery costs.LeanTaaS was founded in 2010 and is headquartered in Santa Clara, California. |  | Series B | Mar 01, 2017 |  |
| Avizia | Avizia is a provider of telehealth and remote conferencing platform to deploy and power system-wide telehealth programs. It is delivering on the vision of collaborative care for patients by connecting medical experts across distance through innovative, leading-edge telemedicine solutions. Supported by Cisco technology, Avizia delivers telemedicinethat is as powerful as it is easy to use. Its end-to-end solution includes telemedicine devices, workflow management software, store-and-forward capabilities with EHR integration, and a line of peripherals, such as digital stethoscopes and examination cameras. Whether medical professionals are performing remote medical consultations or teaching a new procedure, Avizia makes the experience feel as if everyone is present.Avizia uses Cisco TelePresence technology to enable HD, real-time video collaboration in hospitals amongst patients and professionals. | $7M | Series A | Oct 31, 2016 |  |
| Avizia | Avizia is a provider of telehealth and remote conferencing platform to deploy and power system-wide telehealth programs. It is delivering on the vision of collaborative care for patients by connecting medical experts across distance through innovative, leading-edge telemedicine solutions. Supported by Cisco technology, Avizia delivers telemedicinethat is as powerful as it is easy to use. Its end-to-end solution includes telemedicine devices, workflow management software, store-and-forward capabilities with EHR integration, and a line of peripherals, such as digital stethoscopes and examination cameras. Whether medical professionals are performing remote medical consultations or teaching a new procedure, Avizia makes the experience feel as if everyone is present.Avizia uses Cisco TelePresence technology to enable HD, real-time video collaboration in hospitals amongst patients and professionals. |  | Series A | Sep 01, 2016 |  |

10 of 10 investments shown.

## Co-investors
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund, 3 deals together
- [Declaration Partners](https://shizune.co/investors/profile/declaration-partners) — VC Fund, 2 deals together
- [Northwell Ventures](https://shizune.co/investors/profile/northwell-ventures) — VC Fund, 2 deals together
- [Norwest](https://shizune.co/investors/profile/norwest-venture-partners) — VC Fund, 2 deals together
- [Alpha Intelligence Capital](https://shizune.co/investors/profile/alpha-intelligence-capital) — VC Fund, 1 deal together
- [Atlantic Bridge](https://shizune.co/investors/profile/atlantic-bridge) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does New York Presbyterian Ventures invest in?

New York Presbyterian Ventures invests primarily in Health Care, Machine Learning and Artificial Intelligence startups, most often at Series B and Series A stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact New York Presbyterian Ventures?

Public channels for New York Presbyterian Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at New York Presbyterian Ventures?

The team at New York Presbyterian Ventures includes Todd Cohen (Investments), Daniel Barchi (Chief Information Officer) and Jonathan Gordon (Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
